Clinical trial

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

NCT05692674

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-01-10

PhasePHASE2

Study timeline

Study start (estimated)2023-01-10Date precision: day

Registry last updated2023-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

adjuvant hypofractionated intensity-modulated proton radiotherapyRADIATION

Sponsors & collaborators

Shanghai Proton and Heavy Ion Centerlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05692674 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.